Table 4 Univariate and multivariable analyses to identify risk factors of OS

Gender

1.39

0.880–2.190

0.159

Age

0.99

0.979–1.006

0.289

AFP

2.05

1.521–2.763

< 0.001

1.61

1.194–2.182

0.002

HBeAg

1.39

0.994–1.940

0.054

Tumor size

1.15

1.116–1.186

< 0.001

1.08

1.044–1.127

< 0.001

Number

0.53

0.131–2.135

0.371

Poorly differentiation

1.85

1.371–2.507

< 0.001

G stratification

1.06

0.838–1.346

0.620

S stratification

0.94

0.784–1.135

0.537

MVI

2.60

1.912–3.534

< 0.001

1.52

1.096–2.124

0.012

Satellite lesion

3.30

2.282–4.765

< 0.001

2.23

1.521–3.283

< 0.001

Fatty liver

0.73

0.495–1.066

0.103

Capsule

1.88

1.394–2.532

< 0.001

1.38

1.016–1.899

0.039

HBV-DNA

1.59

1.173–2.162

0.002

PT

1.22

1.056–1.417

0.007

INR

5.28

1.117–24.941

0.036

RBC

1.08

0.848–1.385

0.523

HB

0.99

0.985–1.002

0.140

PLR

1.39

1.031–1.874

0.031

NLR

1.68

1.246–2.277

0.001

ALT

1.48

1.101–1.993

0.009

AST

2.41

1.788–3.249

< 0.001

1.70

1.230–2.351

0.001

ALB

1.32

0.650–2.688

0.440

TBIL

0.55

0.176–1.725

0.306

PLT

0.98

0.712–1.357

0.916

FIB-4

1.56

1.143–2.116

0.005